References
- Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV). American Psychiatric Association, 1994
- Ohayon MM, Shapiro CM. Tenses of insomnia epidemiology. J Psychosom Res 2002;53:525-7
- Kupfer DJ, Reynolds CF 3rd. Management of insomnia. N Engl J Med 1997;336:341-6
- Greenblatt DJ. Benzodiazepine hypnotics: sorting the pharmacokinetic facts. J Clin Psychiatry 1991;52(Suppl.):4-10
- Pritchett DB, Seeburg PH. Gamma-aminobutyric acidA receptor alpha 5-subunit creates novel type II benzodiazepine receptor pharmacology. J Neurochem 1990;54:1802-4
- Holm KJ, Goa KL. Zolpidem: an update of its pharmacology, therapeutic efficacy and tolerability in the treatment of insomnia. Drugs 2000;59:865-89
- Vermeeren A. Residual effects of hypnotics: epidemiology and clinical implications. CNS Drugs 2004;18:297-328
- Fleming J MH, Walsh JK, Scharf M, et al. Comparison of the residual effects and efficacy of short term zolpidem, flurazepam, and placebo. Clin Drug Invest 1995;9:303-13
- Orexo. An open randomized three-period crossover study to evaluate the pharmacokinetic profile of sublingual zolpidem for the treatment of short-term insomnia. Study on file; OX22-005 2007
- Staner L, Eriksson M, Cornette F, et al. Sublingual zolpidem is more effective than oral zolpidem in initiating early onset of sleep in the post-nap model of transient insomnia: a polysomnographic study. Sleep Med 2008;10:616-20
- Schaltenbrand N, Lengelle R, Macher JP. Neural network model: application to automatic analysis of human sleep. Comput Biomed Res 1993;26:157-71
- Rechtschaffen A, Kales AA. A manual of standardized terminology techniques and scoring system for sleep stage of human subjects. Washington DC: National Institute of Health, publication 204. Government Printing Officer, 1968
- Parrott AC, Hindmarch I. The Leeds Sleep Evaluation Questionnaire in psychopharmacological investigations – a review. Psychopharmacology 1980;71:173-9
- Bond. The use of analogue scales in rating subjective feelings. Br J Med Psychol 1974;47:211-18
- Wechsler. Echelle d’intelligence de Wechsler pour adultes, forme révisée (WAISR III). Centre de Psychologie Appliquée, 1997
- Smith JM, Misiak H. Critical flicker frequency (CFF) and psychotropic drugs in normal human subjects – a review. Psychopharmacology 1976;47:175-82
- Hindmarch I. Psychomotor function and psychoactive drugs. Br J Clin Pharmacol 1980;10:189-209
- Deacon S, Staner L, Staner C, et al. Effect of short-term treatment with gaboxadol on sleep maintenance and initiation in patients with primary insomnia. Sleep 2007;30:281-7
- Youngstedt SD. Ceiling and floor effects in sleep research. Sleep Med Rev 2003;7:351-65
- Caille G, Spenard J, Lacasse Y, et al. Pharmacokinetics of two lorazepam formulations, oral and sublingual, after multiple doses. Biopharm Drug Dispos 1983;4:31-42
- Fujii. Relative bioavailability of midazolam following sublingual versus oral administration in healthy volunteers. J Pharmacobiodyn 1988;11:206-9
- Orexo. An open labeled clinical trial evaluating the local tolerance and safety of sublingual zolpidem in insomnia patients. Study on file, OX22-007 2007